Mandate

Vinge advises Statoil in connection with transaction concerning Lundin Petroleum and International Petroleum Corporation

February 28, 2017

Vinge advises Statoil ASA (“Statoil”) in connection with a transaction concerning Lundin Petroleum AB (publ) (“Lundin Petroleum”) and International Petroleum Corporation (“IPC”). The board of Lundin Petroleum has proposed to spin-off certain assets outside of Norway into a newly incorporated company, IPC, and to distribute the shares in IPC as dividend in kind to the shareholders of Lundin Petroleum. The intention is to list the shares of IPC on the Toronto Stock Exchange and Nasdaq Stockholm.

Further, the board of IPC has approved that a subsidiary to IPC, after the separate listing, submits a repurchase offer to all shareholders in IPC to acquire shares. Statoil has informed about its intention to sell its shareholding in IPC in the repurchase offer and Statoil has also entered into an agreement with Nemesia, an investment company related to the Lundin family, to sell any remaining shares held by Statoil in IPC to Nemesia which have not been sold through the repurchase offer.

Vinge’s team consists of Dain Hård Nevonen, Göran Nyström and Rikard Lindahl.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025